My Story | O’VISTA Insight
O’VISTA Insight

The Story is Simple,
But Diagnosis Is Not

A personal journey that revealed a critical gap in cognitive health—and inspired a solution to help families get answers sooner, with less stress and more clarity.

The statistics we see regarding Alzheimer’s do not necessarily mean that all these patients actually have Alzheimer’s. There is significant symptom overlap between Alzheimer’s and Frontotemporal Dementia (FTD), and in many healthcare systems, FTD is mistakenly diagnosed as Alzheimer’s.

Even MRI, especially in the early stages, is not a definitive tool for distinguishing between the two. Moreover, it is expensive, time-consuming, and stressful for many seniors.

When I was abroad, my mother delayed her MRI due to fear. The crowded hospital environment, the noise of the machines, and the stress—which was itself part of her brain condition—caused her to wait until I returned. But when I came back, she no longer recognized me.

We were told that Alzheimer’s was the cause. But later, a fundamental question arose: How do we know for sure it was Alzheimer’s and not FTD?

Today we know that misdiagnosis is a real issue, especially in systems where access to advanced tools is limited, time-consuming, or stressful. The result is that part of the diagnostic path either happens too late, or doesn’t happen at all.

The Challenge We Address

Current diagnostic pathways, while powerful, face real-world limitations that delay insight and increase burden on patients and families.

Traditional Methods
  • High Cost
  • Time-Consuming
  • High Stress for Patients
  • Hospital Environment Required
  • Often Late Diagnosis
O’VISTA Approach
  • Cost-Effective
  • Only Takes Minutes
  • Non-Invasive & Calm
  • Can Be Done at Home
  • Early Screening

Symptom Overlap

Alzheimer’s and FTD share early cognitive and behavioral features, increasing risk of misclassification without specialized assessment.

Access & Burden

Advanced imaging and biomarker tests can be costly, time-intensive, geographically limited, and emotionally taxing for patients and families.

Early-Stage Uncertainty

Structural imaging like MRI may not reveal definitive patterns in early disease, leaving clinicians and families in a difficult diagnostic gray zone.

The Missing Link

The issue isn’t that current diagnostic tools are bad. The issue is that a vital link was missing in the chain.

Think of it like before mobile phones. Mobile phones didn’t replace landlines. But they made communication something always accessible, rather than an event limited by place and time. O’VISTA is exactly that missing link in the cognitive health chain.

How O’VISTA Works

We do something different: In minutes, without a hospital environment and without invasive methods, data on eye movements is collected just by looking at a monitor.

Simple Test

The individual looks at a standard monitor for a few minutes. This can even be done in the comfort of their own home.

Calibrated Equipment

We provide calibrated monitors on loan to families so the senior can take the test in a familiar, stress-free environment.

Eye Tracking

Eye movements are recorded—data directly connected to the brain’s attention, executive function, and planning networks.

Cloud Analysis

Data enters the secure O’VISTA cloud for quality control, feature extraction, and standard analysis.

Clinical Insight

Algorithms compare data to cognitive patterns, providing a risk report compatible with Alzheimer’s or FTD.

Better Decisions

Helps clinicians decide: Should this person enter deeper evaluation? Are patterns closer to Alzheimer’s or FTD?

“We do not remove complex diagnoses from the hospital; we make the path to them shorter, earlier, and more bearable.”

“O’VISTA doesn’t take diagnosis away from the hospital; but it ensures the patient gets to the right hospital on time.”

If such a link had existed sooner, perhaps my mother’s path—and many others—would have been different. We created this link so no family has to repeat this experience again.

Start Your Journey Today

With O’VISTA, early and accurate screening for cognitive disorders is within your reach. Without stress, without hospital visits, in the comfort of home.

Contact Us Today
Important Medical Notice O’VISTA is a cognitive screening and clinical decision-support tool. It is not intended to diagnose Alzheimer’s disease, Frontotemporal Dementia (FTD), or any medical condition. Results should be interpreted by qualified healthcare professionals in conjunction with comprehensive clinical evaluation, patient history, and, where appropriate, confirmatory diagnostics. Early screening supports proactive care—but only a licensed clinician can provide a diagnosis.

Advancing compassionate cognitive care through innovation.

© O’VISTA. All rights reserved.